OBJECTIVES: The guidelines and rec-ommendations of good clinical practice have been disrupted by new and urgent policies, marked by the COVID-19 pandemic. Urothelial carcinoma has a signif-icant prevalence in Spain, whose population has been greatly affected by COVID-19, directly by the disease and indirectly by the confinement. The objective of this work is to offer recommendations on protocols and guidelines adjusted to different phases of the pandemic.MATERIAL AND METHODS: This document on the man-agement of bladder carcinoma is based on few evi-dence on urological oncological practice during the first months of the pandemic and on the authors’ experience in this pathology during the crisis of COVID-19. Hospi-tal experts in infectious disseases and radiology have participated to design a common strategy to reorganize the activity.RESULTS: Different proposals for treatment and follow-up of patients diagnosed with bladder cancer adjusted for oncological risk and the different phases of the pandem-ic are presented.CONCLUSIONS: The pandemic’s spread was unimag-inable just a few months ago. Health systems have been shaken by the disease in the most critical phases. It is necessary, at this time, to make an additional effort to develop tools that can facilitate the care of bladder car-cinoma and minimize the impact and risks for patients and health professionals in the future.